Functional Gastrointestinal Disorders

Gastroenterology
1
Pipeline Programs
2
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
1
STW5Phase 24 trials
Active Trials
NCT05389709Completed184Est. May 2023
NCT04656730Completed68Est. Jan 2023
NCT04059900Completed64Est. May 2013
+1 more trials
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
Salix Probiotic BlendN/A1 trial
Active Trials
NCT04155801CompletedEst. Feb 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerSTW5
BayerSTW5
BayerSTW5
Bausch HealthSalix Probiotic Blend
BayerSTW5

Clinical Trials (5)

Total enrollment: 588 patients across 5 trials

NCT04656730BayerSTW5

Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas

Start: Sep 2020Est. completion: Jan 202368 patients
Phase 4Completed
NCT04059900BayerSTW5

Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus

Start: Jun 2009Est. completion: May 201364 patients
Phase 2Completed
NCT05389709BayerSTW5

A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting

Start: Jun 2022Est. completion: May 2023184 patients
N/ACompleted
NCT04155801Bausch HealthSalix Probiotic Blend

A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances

Start: Oct 2019Est. completion: Feb 2020
N/ACompleted
NCT04059783BayerSTW5

Study to Learn More About the Onset of Effect of Iberogast in Patients Suffering From Abnormal Stomach and Intestine Function

Start: Jun 2008Est. completion: Feb 2011272 patients
N/ACompleted

Related Jobs in Gastroenterology

Specialty Representative, Gastroenterology – Minneapolis, Minnesota

AbbVie
Remote
11h ago

Head of Drug Product Development

Ironwood Pharmaceuticals
Boston, Massachusetts, United States
12h ago
$246K - $287K/yr

Regulatory Affairs Associate

Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday

Key Account Director, Diagnostics and Research

Tempus
Remote
Yesterday
$150K - $200K/yr

QA Operation Platform Lead

Johnson & Johnson
Yokneam, Haifa District, Israel
Yesterday

Value Architecture & Engineering Lead

Johnson & Johnson
Titusville, New Jersey, United States of America
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Hepatic Impairment(79)Gastroesophageal Reflux Disease(37)Irritable Bowel Syndrome(29)Gastroesophageal Reflux(27)Liver Transplantation(24)Celiac Disease(23)Hepatic Insufficiency(22)Liver Cirrhosis(22)Gastroesophageal Reflux Disease (GERD)(14)Hepatic Encephalopathy(12)